BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7775118)

  • 21. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of moderate smoking on the central visual field.
    Akarsu C; Yazici B; Taner P; Ergin A
    Acta Ophthalmol Scand; 2004 Aug; 82(4):432-5. PubMed ID: 15291937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of high-pass resolution perimetry in the early diagnosis of primary open-angle glaucoma].
    Yu M; Zhou W; Ye T
    Zhonghua Yan Ke Za Zhi; 1996 Jul; 32(4):267-71. PubMed ID: 9590842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects.
    Kook MS; Cho HS; Seong M; Choi J
    Ophthalmology; 2005 Nov; 112(11):1970-8. PubMed ID: 16185765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Learning effect and test-retest variability of pulsar perimetry.
    Salvetat ML; Zeppieri M; Parisi L; Johnson CA; Sampaolesi R; Brusini P
    J Glaucoma; 2013 Mar; 22(3):230-7. PubMed ID: 22027935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of structural examination methods in the follow-up of patients with ocular hypertension].
    Skorkovská K
    Cesk Slov Oftalmol; 2007 Sep; 63(5):335-41, 344-9. PubMed ID: 17915584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characteristics of blue-on-yellow perimetric thresholds in glaucoma.
    Felius J; de Jong LA; van den Berg TJ; Greve EL
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1665-74. PubMed ID: 7601646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glaucomatous visual field damage. Luminance and color-contrast sensitivities.
    Hart WM; Silverman SE; Trick GL; Nesher R; Gordon MO
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):359-67. PubMed ID: 2303333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli.
    Wall M; Kutzko KE; Chauhan BC
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):426-35. PubMed ID: 9040476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring glaucomatous visual field progression: the effect of a novel spatial filter.
    Strouthidis NG; Scott A; Viswanathan AC; Crabb DP; Garway-Heath DF
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):251-7. PubMed ID: 17197540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescein filling defects of the optic nerve head in normal tension glaucoma, primary open-angle glaucoma, ocular hypertension and healthy controls.
    Plange N; Kaup M; Huber K; Remky A; Arend O
    Ophthalmic Physiol Opt; 2006 Jan; 26(1):26-32. PubMed ID: 16390479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-wavelength automated perimetry can predict glaucomatous standard visual field loss by ten years.
    Sit AJ; Medeiros FA; Weinreb RN
    Semin Ophthalmol; 2004; 19(3-4):122-4. PubMed ID: 15590553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glaucoma detection with frequency doubling perimetry and short-wavelength perimetry.
    Horn FK; Brenning A; Jünemann AG; Lausen B
    J Glaucoma; 2007; 16(4):363-71. PubMed ID: 17570999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Color perimetry for assessment of primary open-angle glaucoma.
    Sample PA; Weinreb RN
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1869-75. PubMed ID: 2211033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes.
    Henson DB; Chaudry S; Artes PH; Faragher EB; Ansons A
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):417-21. PubMed ID: 10670471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.